Sophie Papa

• Member of the Board of Directors of Orion Corporation since 24 March 2026
• Member of the Personnel and Remuneration Committee, member of the R&D Committee
• Independent of the company and its significant shareholders

Career

2024- Consulting Venture Partner, RA Capital 
2024- Chief Medical Officer, NexCure 
2024- Consulting Chief Medical Officer, Sastra Cell Therapy 
2022- Chief Medical Officer, Head of Translational Science, Enara Bio 
2018- Clinical Reader (Associate Professor) in Immune Oncology, King’s College London 
2014-2021 Honorary Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation 
Trust 
2014-2018 Senior Lecturer, King’s College London 
2011-2014 Clinical Lecturer Medical Oncology, King’s College London 
2008-2011 Clinical Research Fellow, King’s College London

Current key positions of trust

Leadership and governance

Member of the Board: Orion Corporation 2026, T Knife Therapeutics 2025-

Cell Therapy Programme Director for IEC JACIE accreditation GSTFT 
Chair of the Biosafety Committee, GSTFT 
Chair of the Skin Cancer Research Team, GSTFT 
Chair of the IEC working group 
GSTFT Cell, Regenerative Medicine and Genetics Board Member 
Member GSTFT GMP Steering Committee 
Lead for Theme 2: Immunotherapy, CRUK Cancer Centre, King’s Health Partners 
Cancer Immunology and Immunotherapy Programme lead, KCL 
Member of the Joint Oncology, Haematology Clinical Trials Leads Committee 
Member of the HCA Skin Cancer Board 
Member of the HCA Immunotherapy and Genetics Board

External committee memberships

CAR-T Cell Advisory Group member 2020-2021 working group, NHS England 
BSBMT-Cell Therapy Group Member 
Member BSI-NCRI Cancer Immunology Group 
’50 Movers and Shakers in BioBusiness. BioBeat Panel member: A summit to explore the UK advantage in Cell and Gene Therapy November 2019

Prior consulting and advisory boards

Advisory roles: T-Knife, RemedyBio, EnaraBio, Zelluna, GSK, AdicetBio, MSD, BMS, Gritstone, Roche, 
Amgen, Achilles 
Scientific Advisory Board Member: Zelluna, Leucid Bio, RemedyBio